MNPR
Monopar Therapeutics Inc. · HEALTHCARE
Insiders bought $105K of Monopar Therapeutics Inc. in the last 12 months
1 insider bought on 1 day.
$105KBought, 12 mo
$4.4MSold, 12 mo
$465.0MMarket cap
MNPR over the last year
Largest buyers, last 12 months
MNPR after insider buys
3 months after each buy, from the first price a copier could get.
+3.0%Average
+2.2 ptsVs S&P 500
1 of 3Higher
3 buys since 2024 with 3 months of prices.
Every filing
9 insider filings since 2021, newest first
MNPRSell
Christopher M Starr · Director
$659K−61.9%Oct 5
MNPRSell
Chandler Robinson · Chief Executive Officer
$2.6M−22.6%Sep 28
MNPRSell
Kim R Tsuchimoto · Director
$456K−35.6%Aug 27
MNPRSell
Raymond Anderson · Director
$351K−11.7%Aug 27
MNPRBuy
Quan Anh Vu · CFO
$105KDec 29
MNPRSell
Arthur J Klausner · Director
$344K−37.0%Dec 19
MNPRBuy
Andrew Cittadine · COO
$26K+21.0%Jun 21
MNPRBuy
Andrew Cittadine · COO
$33K+31.0%Jun 17
MNPRSell
Tactic Pharma LLC · 10% owner
$1.8M−3.0%Feb 16
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.